With a first-of-its-kind GMP facility, AbCellera Biologics is building the future of Canadian biotech, right here in BC
The newly-announced 130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.
Two months after breaking ground on its new Vancouver headquarters, BC biotech giant AbCellera announced that its building a 130,000-square-foot Good Manufacturing Practices (GMP) manufacturing facility for the production of therapeutic antibodies, a first of its kind in Canada.
(GMP is a sys…